Brevan Howard Capital Management »

Apellis Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $575k 20k 28.84
2024-03-31 $612k 10k 58.78
2023-12-31 $260k 4.3k 59.86
2023-06-30 $207k 2.3k 91.10

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Ftse/xinhua China 25 China Lg-cap Etf Call Option (FXI)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Industrial Select Sect Spdr Indl Call Option (XLI)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Spdr S&p Biotech Etf S&p Biotech (XBI)
KraneShares CSI China Internet ETF Csi Chi Internet Call Option (KWEB)
Energy Select Sector Spdr Energy Call Option (XLE)
Alibaba Group Holding Sponsored Ads (BABA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Brevan Howard Capital Management

Top funds holding Apellis Pharmaceuticals

EcoR1 Capital
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Braidwell
Octagon Capital Advisors
T. Rowe Price Investment Management
Deep Track Capital
Logos Global Management
Siren
Assenagon Asset Management
Morgan Stanley
Jennison Associates

View all funds holding Apellis Pharmaceuticals